SIGA Valuation

SIGA Technologies Inc

Add to Watchlist

Advanced Chart

8.750

-0.03(-0.342%)1D

Overview
Forecast
Valuation
Earnings

SIGA Relative Valuation

SIGA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SIGA is overvalued; if below, it's undervalued.

Historical Valuation

SIGA Technologies Inc (SIGA) is now in the Fair zone, suggesting that its current forward PE ratio of 11.15 is considered Fairly compared with the five-year average of 8.12. The fair price of SIGA Technologies Inc (SIGA) is between 3.91 to 10.31 according to relative valuation methord.

Relative Value

Fair Zone

3.91-10.31

Current Price：8.75

Fair

11.15

Trailing

Forward

6.55

EV/EBITDA

SIGA Technologies Inc. (SIGA) has a current EV/EBITDA of 6.55. The 5-year average EV/EBITDA is 4.27. The thresholds are as follows: Strongly Undervalued below -3.80, Undervalued between -3.80 and 0.24, Fairly Valued between 8.30 and 0.24, Overvalued between 8.30 and 12.34, and Strongly Overvalued above 12.34. The current Forward EV/EBITDA of 6.55 falls within the Historic Trend Line -Fairly Valued range.

6.60

EV/EBIT

SIGA Technologies Inc. (SIGA) has a current EV/EBIT of 6.60. The 5-year average EV/EBIT is 3.85. The thresholds are as follows: Strongly Undervalued below -4.83, Undervalued between -4.83 and -0.49, Fairly Valued between 8.18 and -0.49, Overvalued between 8.18 and 12.52, and Strongly Overvalued above 12.52. The current Forward EV/EBIT of 6.60 falls within the Historic Trend Line -Fairly Valued range.

4.63

SIGA Technologies Inc. (SIGA) has a current PS of 4.63. The 5-year average PS is 3.47. The thresholds are as follows: Strongly Undervalued below -0.42, Undervalued between -0.42 and 1.52, Fairly Valued between 5.42 and 1.52, Overvalued between 5.42 and 7.37, and Strongly Overvalued above 7.37. The current Forward PS of 4.63 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

SIGA Technologies Inc. (SIGA) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

SIGA Technologies Inc. (SIGA) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

SIGA Technologies Inc (SIGA) has a current Price-to-Book (P/B) ratio of 3.00. Compared to its 3-year average P/B ratio of 3.00 , the current P/B ratio is approximately 0.04% higher. Relative to its 5-year average P/B ratio of 3.67, the current P/B ratio is about -18.14% higher. SIGA Technologies Inc (SIGA) has a Forward Free Cash Flow (FCF) yield of approximately 18.95%. Compared to its 3-year average FCF yield of 10.96%, the current FCF yield is approximately 72.84% lower. Relative to its 5-year average FCF yield of 9.87% , the current FCF yield is about 91.95% lower.

3.00

P/B

Median3y

3.00

Median5y

3.67

18.95

FCF Yield

Median3y

10.96

Median5y

9.87

Competitors Valuation Multiple

The average P/S ratio for SIGA's competitors is 17.11, providing a benchmark for relative valuation. SIGA Technologies Inc Corp (SIGA) exhibits a P/S ratio of 4.63, which is -72.94% above the industry average. Given its robust revenue growth of 271.92%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SIGA.O

SIGA Technologies Inc

Maze Therapeutics Inc

Loss

0.00

KROS.O

Keros Therapeutics Inc

Bicara Therapeutics Inc

Loss

634.57M

ORKA.O

Oruka Therapeutics Inc

Loss

553.90M

KALV.O

Kalvista Pharmaceuticals Inc

18.51

647.40M

Performance Decomposition

Market capitalization of SIGA decreased by 3.10% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 8.40 to 43.74.

The secondary factor is the Revenue Growth, contributed 271.92%to the performance.

Overall, the performance of SIGA in the past 1 year is driven by Margin Expansion. Which is more sustainable.

271.92%

21.81M → 81.12M

Revenue Growth

420.71%

8.40 → 43.74

Margin Expansion

-695.73%

-1.29 → 7.71

P/E Change

-3.10%